Tibet Rhodiola Pharmaceutical Holding – World Class Benchmarking
Company: Tibet Rhodiola Pharmaceutical Holding Company
Bloomberg ticker: 600211 SH
Market cap: US$4,139m
Background: Tibet Rhodiola Pharmaceutical Holding Company manufactures and wholesales pharmaceutical products. Its main products include Chinese patent medicine, biological products, and chemical medicine. Tibet Rhodiola Pharmaceutical Holding is headquartered in Lhasa, China.
World Class Benchmarking of Tibet Rhodiola Pharmaceutical Holding
- Profitable Growth rank of 2 was same compared to the prior period’s 2nd rank
- This is World Class performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 1 was better than its Growth rank of 2
- Profitability rank of 1 was up compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 4th rank
- This is World Class performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.